This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anygen Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Hong Won Suh in Calcium Channel Research.
Introduction
Hong Won Suh is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biochemistry, particularly in the study of calcium channels. His work focuses on enhancing the binding properties of conotoxins, which are peptides derived from marine snails.
Latest Patents
Hong Won Suh holds a patent related to Omega conotoxins. The patent describes a method for increasing the binding reversibility of a ω-conotoxin to an N-type calcium channel. This involves preparing a ω-conotoxin with specific amino acid residues that improve its binding characteristics. The invention also includes a novel ω-conotoxin and a pharmaceutical composition that exhibits enhanced blocking activity and specificity towards the N-type calcium channel.
Career Highlights
Hong Won Suh is associated with Anygen Co., Ltd., where he continues to advance his research in the field. His innovative approaches have the potential to lead to new therapeutic options for conditions related to calcium channel dysfunction.
Collaborations
He has collaborated with notable colleagues, including Jae Ii Kim and Hye Whon Rhim, to further his research endeavors.
Conclusion
Hong Won Suh's work in the development of Omega conotoxins represents a significant advancement in the understanding of calcium channels. His contributions may pave the way for new treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile